Avingtrans Plc · LSE:AVG

Avingtrans — H1 FY2018 Earnings Presentation

39 slides from Avingtrans's earnings presentation, February 2018

  1. Slide 1: Results: 6 months ended November 2017

    RESULTS: 6 months ended November 2017 Steve McQuillan – Chief Executive Officer Stephen King – Chief Financial Officer 1

  2. Slide 2: Financial Highlights

    Financial Highlights HTG integration proceeding to plan  Revenue increased to £26.9m (2017 H1: £9.6m)  Excluding HTG, organic revenue increased by 14.9%  Adjusted Group EBITDA advanced to £1.1m (2017 H1: £0.0m)  Adjusted loss before tax £0.1m (2017 H1: loss £0.2m)  Adjusted diluted EPS 0.4p (20

  3. Slide 3: Operational Highlights

    Operational Highlights  Transformative acquisition of Hayward Tyler Group plc (HTG) – good progress to date  Scientific Magnetics and Whiteley Read acquisitions also being fully integrated  Two new divisions being created within Energy sector; Medical separation underway  Improving orders and po

  4. Slide 4: HTG Integration

    HTG Integration Progress so far  Opening balance sheet clean-up complete  Banking facilities operating normally, within covenants in the UK and USA  Duplicate board and advisory costs all removed  Creditors position now stable – routine trading terms  Debt levels as expected at this stage – cas

  5. Slide 5: Proposed New Divisional Structure

    Proposed New Divisional Structure ENERGY MEDICAL ENGINEERED PUMPS PROCESS SOLUTIONS MEDICAL & INDUSTRIAL & MOTORS & ROTATING EQUIPMENT IMAGING President/Divisional MD President/Divisional MD Acting Divisional MD Mike Turmelle Austen Adams Austen Adams 5

  6. Slide 6: Energy

    Energy Designs and manufactures safety critical equipment for the energy sectors, including oil & gas extraction, fossil fuels and nuclear process plant, pressure and vacuum vessels and components. Engineered Pumps and Motors  Aftermarket organisation strengthened,  New Chinese factory in Kunshan

  7. Slide 7: Medical

    Medical Designs and manufactures safety critical equipment for the medical, biomedical, science and industrial sectors. Medical and Industrial Imaging  Revenue and adjusted EBIT show slight improvement  Core MRI business at Metalcraft is steady  China – new contract ramp up has been slow to build

  8. Slide 8: Financials

    (Avingtrans plc ) Financials

  9. Slide 9: Profit and Loss Account

    Profit and Loss Account H1 FY18 H1 FY17 £m £m Revenue 26.9 9.6 Gross Profit 6.1 1.4 Gross Profit margin 22.6% 14.6% Adjusted EBITDA 1.1 0.0 Adjusted EBITDA margin 4.1% - Adjusted loss before tax (0.1) (0.2) Loss after tax (4.3) (0.5) EPS – Continuing Adj. Fully Dil.1 0.4p (0.4)p Basic (19.6)p (1.9)p

  10. Slide 10: Adjusted Divisional EBITDA

    Adjusted Divisional EBITDA Energy(H) Energy(A) Medical Central H1 FY18 Energy(A) Medical Central H1 FY17 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 Operating profit/(loss) (2,928) 333 75 (2,070) (4,590) (103) 54 (677) (726) Share-based payments - 10 6 16 32 1 1 5 7 Restructuring costs 1,2

  11. Slide 11: Dividend Growth

    Dividend Growth 4.0 3.5 3.0 2.5 2.2 Pence 2.1 2.0 2.0 1.8 1.5 1.5 1.0 1.2 1.3 0.5 1.0 1.1 0.9 0.7 0.0 FY13 FY14 FY15 FY16 FY17 FY18 Interim Final 18 11

  12. Slide 12: HTG - Net Assets Bridge (March to August 2017)

    HTG - Net Assets Bridge (31 March 17 to 31 August 17) 25 20 (5.7) (1.1) 15 (1.2) £m (3.7) 22.4 10 5 (10.3) 0.4 0 March 2017 Asset Pension & FX Tax losses Acquisition Trading August 2017 impairment derivatives derecognised costs losses 12 12

  13. Slide 13: Balance Sheet

    Balance Sheet 30 Nov 2017 31 May 2017 30 Nov 2016 £m £m £m Fixed Assets 27.8 4.9 4.6 Goodwill 20.6 5.2 4.6 Other Intangible 20.2 1.4 1.0 Deferred Tax Asset/Pension Obligation 1.6 - - Working Capital 19.5 7.4 7.0 Provisions (6.4) - - Tax 1.4 0.1 - Net (Debt)/Cash (8.2) 26.4 27.8 Creditors >1 year (3.

  14. Slide 14: Cash Flow

    Cash Flow H1 FY18 H1 FY17 £m £m Total EBITDA (2.0) (0.3) Net Working cap (8.7) (3.1) Interest, Tax and Other 0.1 0.1 Dividend (0.2) (0.3) Issue of new shares - 0.3 Acquisition - - Purchase of shares – Tender buyback - (19.4) Capex (1.1) (0.2) Net Cash Flow (11.9) (22.9) Opening Net Cash/ (Debt) 26.4

  15. Slide 15: AVG – Net Debt Bridge H1 FY17

    AVG – Net Debt Bridge H1 FY17 30 (1.1) (1.4) 26.4 (1.5) (3.0) 25 (3.7) 20 (2.0) (1.1) (0.2) (22.4) 15 £m 10 5 0 -5 (0.4) (8.2) -10 June 2017 EBITDA Restructing AVG acqn HTG HTG Net WCap Cap Ex Dividend HTG net FX & other November costs costs creditor disposal change Acqn debt 2017 o'hang costs 15 15

  16. Slide 16: Summary

    (Avingtrans plc ) Summary

  17. Slide 17: Summary

    Summary  Successful initial integration of Hayward Tyler and Peter Brotherhood  Strong order book growth in Energy; Medical primed for growth in coming year  Nuclear life extension wins in the UK, USA, Sweden and S. Korea  Sellafield 3M3 project on plan: technically, operationally and commercial

  18. Slide 18: Compelling Pinpoint-Invest-Exit Strategy

     Compelling Pinpoint-Invest-Exit Strategy  Niche market leadership positions  Consistent shareholder returns 18

  19. Slide 19: Energy Overview

    (Avingtrans ple ) engineering tec hnology group Energy Overview

  20. Slide 20: Energy - Markets

    Energy - Markets Oil & Gas / Downstream Oil & Gas / Upstream Chemical & Processing Defence Power Gen / Power Gen / Power Gen / De-centralised Energy Fossil Nuclear + Decommissioning Clean + Renewables Production + Storage Specialist Original Equipment and Comprehensive Through Life Support across al

  21. Slide 21: Energy - Offering

    Energy - Offering Performance-critical solutions for energy systems We design, engineer, manufacture and provide comprehensive through life support for performance-critical power, pump, process and storage solutions for the global energy sector. Our product portfolio of specialist motors, pumps, tur

  22. Slide 22: Energy - Brands

    Energy - Brands Energy systems solutions Specialist Original Equipment and Comprehensive Through Life Support Market leader in the design, manufacture Specialist turbines and compressors and through life support of performance- for power generation, marine, sugar, petrochemical and critical motors a

  23. Slide 23: Energy - Product Suite

    Energy - Product Suite Integrated energy systems - design, engineer, manufacture and service. POWER Steam Turbines Subsea motors Submersible motors CHP & Gas-to-Power Permanent magnet generators PUMP Canned Motor Pump / ASME S3 Reciprocating Boiler circulating pumps Gear Pumps Canned Motor Retrofits

  24. Slide 24: Energy - Through Life Support / Aftermarket

    Energy - Through Life Support / Aftermarket ~90% of total life cycle cost is after equipment is purchased and installed Continued safe and efficient operation of facilities across the energy markets is fundamental in todays socioeconomic environment Older facilities are being operated beyond their o

  25. Slide 25: Energy – 5D Through Life Support Model

    Energy – 5D Through Life Support Model The Five Dimensional (5D) through-life support model – developed around customer needs Designed to be simple, but comprehensive and covers all aspects of support for customers that might be needed during the lifecycle of owning, operating and maintaining their

  26. Slide 26: Energy – Strategic Alliances

    Energy – Strategic Alliances  Leading Japanese manufacturer  Global market leader in  Number 1 nuclear pump of pumps for energy, oil & gas, subsea systems manufacturer in China and general industry sectors  HT is manufacturing permanent  HT and Apollo will co-develop  HT will supply BCPs and o

  27. Slide 27: Medical Overview

    (Avingtrans pic) Medical Overview

  28. Slide 28: Medical - Markets

    Medical - Markets Magnetic Resonance Imaging MRI Proton Therapy Nuclear Magnetic Resonance NMR Security screening Specialist Original Equipment and Solid State Physics Through Life Support for NMR systems 28

  29. Slide 29: Medical - Brands

    Medical - Brands Medical systems solutions Specialist Original Equipment and Through Life Support for NMR Systems Superconducting magnets • Expertise in MRI and NMR magnet technology • Partnership with MR Resources for NMR services Cryogenic vacuum vessels Niche market leadership in: • magnetic reso

  30. Slide 30: Medical - Through Life Support / Aftermarket

    Medical - Through Life Support / Aftermarket  New partnership launched in January 2018, to provide independent NMR service in Europe  Multiple service contract enquiries already received for a variety of systems  Currently installing a Varian NMR system in our factory for demo/resale  A second V

  31. Slide 31: Appendix

    (Avingtrans pic) engine technology grour Appendix

  32. Slide 32: Proposed New Divisional Structure

    Proposed New Divisional Structure Engineered Pumps and Process Solutions and Medical and Industrial Motors Rotating Equipment Imaging HT Inc Metalcraft UK (Energy) Metalcraft UK (Medical) HT Luton Peter Brotherhood Metalcraft China HT China Maloney Scientific Magnetics HT India (HT) Fluid Handling C

  33. Slide 33: Our Locations

    Our Locations 560 Employees 104 Employees 54 Employees 11 Employees Low cost sourcing strategy appealing to OEM customers 33

  34. Slide 34: Blue Chip Key Accounts

    (Avingtrans plc) Blue Chip Key Accounts asinine sections ove ® Sellafield Ltd | SIEMENS | ‘F TechnioFmc Jalltech] Medical Systems € © De@DFENERGY Rapiscan systems OY BRUKER Cir) ch BL ERR Zhongke-Niujin

  35. Slide 35: Market Capitalisation History

    Market Capitalisation History Purchased Moss & Placing £3.5m 2009 8 Purchased Sigma1 2010 9 2011 15 2012 17 Sold JenaTec; Purchased Aerotech & PFW 2013 32 Purchased Maloney 2014 45 Oil Price Shock Purchased RMDG 2015 31 Purchased Rolls Royce pipes; Sold Sigma 2016 50 Returned £19.4m to shareholders;

  36. Slide 36: 5 Year History: Revenue and EBITDA

    5 Year History: Revenue and EBITDA (excl. Sigma/Aerospace) 25 0.72 0.8 23.7 22.6 22.7 0.6 20 21.2 0.4 17.5 0.35 0.3 0.2 15 0 10 -0.2 -0.4 5 -0.45 -0.55 -0.6 0 -0.8 FY13 FY14 FY15 FY16 FY17 Revenue (£M LHS) EBITDA (£M RHS) adjusted to continuing operations (excluding Sigma) 16 36

  37. Slide 37: M&A Strategy (PIE)

    M&A Strategy (PIE) • Defendable markets • Bought Scientific Magnetics • Unconsolidated engineering niches • Enabling acquisition for Medical div. PINPOINT • Good businesses, or subscale entities • Bought Hayward Tyler • Acquisitions at competitive prices • Transforming acquisition for Energy div. •

  38. Slide 38: M&A Strategy – Brand Building

    M&A Strategy – Brand Building Brand Acquisitions Bought for £m1 Sold for £m1 JRT Ltd JenaTec Inc 4.0 14.5 JGWT GMBH (FY02 - FY09) (FY13) Boneham & Turner Moss Group Sigma Components B&D Patterns C&H Composites Eng Group 22.0 65.0 Aerotech Tubes (FY07 - FY16) (FY16) PFW Farnborough RMDG Rolls Royce N

  39. Slide 39: Long Term Investors

    Long Term Investors % of issued share Shareholder capital owned Nigel Wray 9.7 Funds Managed by Unicorn Asset Management Ltd 6.3 Harwood Capital 6.1 Funds Managed by RBC Trustees Limited 5.5 R S McDowell’s Pension Fund 4.5 P McDowell’s Pension Fund 3.9 Funds Managed by LGT Bank 3.3 Other Board Membe

Avingtrans — H1 FY2018 Earnings Presentation on 6ix